These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

231 related articles for article (PubMed ID: 33838035)

  • 1. HDL: Fact, fiction, or function? HDL cholesterol and cardiovascular risk.
    Allard-Ratick MP; Kindya BR; Khambhati J; Engels MC; Sandesara PB; Rosenson RS; Sperling LS
    Eur J Prev Cardiol; 2021 Apr; 28(2):166–173. PubMed ID: 33838035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cholesterol Efflux Capacity, High-Density Lipoprotein Particle Number, and Incident Cardiovascular Events: An Analysis From the JUPITER Trial (Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin).
    Khera AV; Demler OV; Adelman SJ; Collins HL; Glynn RJ; Ridker PM; Rader DJ; Mora S
    Circulation; 2017 Jun; 135(25):2494-2504. PubMed ID: 28450350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HDL cholesterol efflux capacity and incident cardiovascular events.
    Rohatgi A; Khera A; Berry JD; Givens EG; Ayers CR; Wedin KE; Neeland IJ; Yuhanna IS; Rader DR; de Lemos JA; Shaul PW
    N Engl J Med; 2014 Dec; 371(25):2383-93. PubMed ID: 25404125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-density lipoprotein cholesterol efflux capacity and cardiovascular risk in autoimmune and non-autoimmune diseases.
    Hafiane A; Favari E; Daskalopoulou SS; Vuilleumier N; Frias MA
    Metabolism; 2020 Mar; 104():154141. PubMed ID: 31923386
    [TBL] [Abstract][Full Text] [Related]  

  • 5. HDL regulates the risk of cardiometabolic and inflammatory-related diseases: Focusing on cholesterol efflux capacity.
    Kang H; Song J; Cheng Y
    Int Immunopharmacol; 2024 Sep; 138():112622. PubMed ID: 38971111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Could high-density lipoprotein cholesterol predict increased cardiovascular risk?
    Chang TI; Streja E; Moradi H
    Curr Opin Endocrinol Diabetes Obes; 2017 Apr; 24(2):140-147. PubMed ID: 28099207
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leisure time physical activity is associated with improved HDL functionality in high cardiovascular risk individuals: a cohort study.
    Hernáez Á; Soria-Florido MT; Castañer O; Pintó X; Estruch R; Salas-Salvadó J; Corella D; Alonso-Gómez Á; Martínez-González MÁ; Schröder H; Ros E; Serra-Majem L; Fiol M; Lapetra J; Gomez-Gracia E; Fitó M; Lassale C
    Eur J Prev Cardiol; 2021 Oct; 28(12):1392-1401. PubMed ID: 34647580
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Non-high-density lipoprotein (non-HDL) cholesterol in adolescence as a predictor of atherosclerotic cardiovascular diseases in adulthood.
    Shoar S; Ikram W; Shah AA; Farooq N; Gouni S; Khavandi S; Tabibzadeh E; Khavandi S
    Rev Cardiovasc Med; 2021 Jun; 22(2):295-299. PubMed ID: 34258898
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-Density Lipoprotein Functionality as a New Pharmacological Target on Cardiovascular Disease: Unifying Mechanism That Explains High-Density Lipoprotein Protection Toward the Progression of Atherosclerosis.
    Favari E; Thomas MJ; Sorci-Thomas MG
    J Cardiovasc Pharmacol; 2018 Jun; 71(6):325-331. PubMed ID: 29528874
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation Alters Relationship Between High-Density Lipoprotein Cholesterol and Cardiovascular Risk in Patients With Chronic Kidney Disease: Results From KNOW-CKD.
    Kim JY; Park JT; Kim HW; Chang TI; Kang EW; Ahn C; Oh KH; Lee J; Chung W; Kim YS; Kim SW; Yoo TH; Kang SW; Han SH;
    J Am Heart Assoc; 2021 Aug; 10(16):e021731. PubMed ID: 34369187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fully automated immunoassay for cholesterol uptake capacity to assess high-density lipoprotein function and cardiovascular disease risk.
    Murakami K; Harada A; Toh R; Kubo T; Miwa K; Kim J; Kiriyama M; Iino T; Nishikawa Y; Uno SN; Akatsuchi K; Nagao M; Ishida T; Hirata KI
    Sci Rep; 2023 Feb; 13(1):1899. PubMed ID: 36732570
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-density lipoprotein function, dysfunction, and reverse cholesterol transport.
    Fisher EA; Feig JE; Hewing B; Hazen SL; Smith JD
    Arterioscler Thromb Vasc Biol; 2012 Dec; 32(12):2813-20. PubMed ID: 23152494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HDL in the 21st Century: A Multifunctional Roadmap for Future HDL Research.
    Rohatgi A; Westerterp M; von Eckardstein A; Remaley A; Rye KA
    Circulation; 2021 Jun; 143(23):2293-2309. PubMed ID: 34097448
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The High-Density Lipoprotein Puzzle: Why Classic Epidemiology, Genetic Epidemiology, and Clinical Trials Conflict?
    Rosenson RS
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):777-82. PubMed ID: 26966281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. From High-Density Lipoprotein Cholesterol to Measurements of Function: Prospects for the Development of Tests for High-Density Lipoprotein Functionality in Cardiovascular Disease.
    Sacks FM; Jensen MK
    Arterioscler Thromb Vasc Biol; 2018 Mar; 38(3):487-499. PubMed ID: 29371248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-density lipoprotein revisited: biological functions and clinical relevance.
    von Eckardstein A; Nordestgaard BG; Remaley AT; Catapano AL
    Eur Heart J; 2023 Apr; 44(16):1394-1407. PubMed ID: 36337032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High-density lipoprotein-mediated anti-atherosclerotic and endothelial-protective effects: a potential novel therapeutic target in cardiovascular disease.
    Besler C; Heinrich K; Riwanto M; Lüscher TF; Landmesser U
    Curr Pharm Des; 2010 May; 16(13):1480-93. PubMed ID: 20196740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HDL and Reverse Cholesterol Transport Biomarkers.
    Riggs KA; Rohatgi A
    Methodist Debakey Cardiovasc J; 2019; 15(1):39-46. PubMed ID: 31049148
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-Density Lipoprotein Anti-Inflammatory Capacity and Incident Cardiovascular Events.
    Jia C; Anderson JLC; Gruppen EG; Lei Y; Bakker SJL; Dullaart RPF; Tietge UJF
    Circulation; 2021 May; 143(20):1935-1945. PubMed ID: 33840204
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipid phenotypes at the extremes of high-density lipoprotein cholesterol: The very large database of lipids-9.
    Quispe R; Al-Hijji M; Swiger KJ; Martin SS; Elshazly MB; Blaha MJ; Joshi PH; Blumenthal RS; Sniderman AD; Toth PP; Jones SR
    J Clin Lipidol; 2015; 9(4):511-8.e1-5. PubMed ID: 26228668
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.